Switching diabetes treatment after short-term intensive insulin
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests how well different diabetes medications work after a brief period of intensive insulin therapy. It may help you find a simpler, effective treatment plan tailored to your needs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes for more than 1 year but less than 15 years.
- You are currently taking at least one diabetes pill (like metformin) at a stable dose for at least 3 months.
- Your A1c (average blood sugar over 3 months) is above a certain level depending on how many pills you take.
- You are between 18 and 70 years old.
- Your body mass index (BMI) is between 20 and 35.
- You are willing to use insulin, check your blood sugar, and follow lifestyle advice.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a combination of three diabetes medicines (henagliflozin, retagliptin, and metformin) in people newly diagnosed with type 2 diabetes. The goal is to see if this triple therapy works better for controlling blood sugar compared to standard treatments.
This trial tests different ways to start a new long-acting insulin called icodec for people with type 2 diabetes. It looks at how to give an extra dose on day 4 to help control blood sugar better.
This study compares a continuous “under the skin” diabetes medicine (called beinaglutide) with an insulin pump (CSII) in people who were recently diagnosed with type 2 diabetes. It aims to see which approach works better and is safer for controlling blood sugar.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This study tests if adding a non-insulin medication can lower the amount of insulin needed while improving heart and metabolic health in people with type 1 diabetes. It may also help understand how this approach works in people with a genetic form of diabetes (GCK-MODY).
This study tests if starting two newer diabetes drugs (empagliflozin and semaglutide) soon after diagnosis, along with metformin, helps control blood sugar better than metformin alone. It's for people diagnosed with type 2 diabetes in the last two years who are already taking a high dose of metformin.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.